Who Paid My Doc
Roy Beveridge
Medical Oncology Fairfax, VA Medical Doctor
NPI 1528035532 CMS profile 435060
8503 Arlington Blvd, Suite 400, Fairfax, VA 22031
General payments
$216,305
Research payments
$0
Ownership & investment interest
$169,986
Through program year 2024, Roy Beveridge of Fairfax, VA is reported in the CMS Open Payments database as having received $216,305 across 18 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $169,986 across 6 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 94th percentile of Medical Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $3,263 | 6 | |
| 2023 | General | $210,049 | 9 | |
| 2022 | General | $2,993 | 3 | |
| 2024 | Ownership | $84,993 | 3 | |
| 2023 | Ownership | $84,993 | 3 |
Beside peers
- Roy Beveridge
- Medical Oncology median
- Middle half of Medical Oncology
- National median
In program year 2025, general payments to Roy Beveridge were reported at $0. Among 3,316 Medical Oncology profiles paid that year, the median was $1,128 and the middle half received between $147 and $5,675.
Show as a table
| Year | Roy Beveridge | Medical Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $968 | $140–$6,658 | $163 |
| 2020 | $0 | $747 | $102–$5,891 | $114 |
| 2021 | $0 | $430 | $50–$4,098 | $132 |
| 2022 | $2,993 | $812 | $127–$4,907 | $149 |
| 2023 | $210,049 | $957 | $144–$5,248 | $160 |
| 2024 | $3,263 | $1,042 | $149–$5,650 | $164 |
| 2025 | $0 | $1,128 | $147–$5,675 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
18 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Medical Oncology in Virginia
Janakiraman Subramanian
Medical Oncology · Fairfax, VA
Alexander Spira
Medical Oncology · Fairfax, VA
Robert Dreicer
Medical Oncology · Charlottesville, VA
Kathleen Harnden
Medical Oncology · Fairfax, VA
Jeanny Aragon-Ching
Medical Oncology · Falls Church, VA
Nagla Abdel Karim
Medical Oncology · Fairfax, VA
Related records
Medical Oncology in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Medical Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.